生活方式和饮食改变对子宫内膜异位症发展和症状管理的影响
Amber Trujillo Lalla1, Christina Onyebuchi, Elisa Jorgensen
1Massachusetts General Hospital, Division of Minimally Invasive Gyne-cologic Surgery, Department of Obstetrics and Gynecology, Boston, Massachusetts, USA.
Current opinion in obstetrics & gynecology
|June 13, 2024
概括
饮食和炼等生活方式因素显示出治疗子宫内膜异位症的潜力,但研究有限. 需要进行进一步的研究,以制定明确的指导方针,用于自我管理和改变子宫内膜异位症护理中的生活方式.
科学领域:
- 妇科 妇科 妇科 妇科
- 生殖健康 生殖健康
- 环境健康 环境健康
背景情况:
- 子宫内膜异位症的管理是复杂的,对生活方式影响的研究有限.
- 患者寻求有关生活方式选择如何影响其病情的信息.
- 自主管理和生活方式的改变被用作辅助疗法,没有具体的指导方针.
研究的目的:
- 审查生活方式对子宫内膜异位症的影响.
- 探索潜在的自我管理和生活方式治疗疗法.
- 确定在子宫内膜异位症护理中需要进一步研究的领域.
主要方法:
- 对生活方式因素和子宫内膜异位症的研究进行文献综述.
- 对将环境暴露与子宫内膜异位症联系起来的数据进行分析.
- 对饮食和运动干预措施的证据评估.
- 评估用于症状管理的心身实践.
主要成果:
- 内分泌干扰化学物质 (EDC) 和子宫内膜异位症之间存在潜在的联系.
- 地中海饮食可能对子宫内膜异位症管理有好处.
- 运动和像这样的身心练习有希望,但需要更多的研究.
- 目前,有限的证据支持特定的生活方式干预.
结论:
- 关于生活方式影响和子宫内膜异位症治疗的数据很少.
- 高质量的未来研究对于指导临床实践至关重要.
- 需要更多的研究来了解EDC暴露和子宫内膜异位症的联系.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Irritable Bowel Syndrome III: Medical and Nursing Management
194
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
194
Disorders of the Female Reproductive System
347
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
347
Oogenesis
63.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.6K
Drugs for Treatment of Constipation-Predominant IBS
155
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
155
Drugs for Treatment of Diarrhea-Predominant IBS
157
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
157


